CHINA PHARMA HOLDINGS, INC. Accounts Receivable, after Allowance for Credit Loss
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accounts Receivable, after Allowance for Credit Loss of $11.35 million as of 2015-06-30, per its 10-Q filed 2015-12-28.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsReceivableNet · last filed 2015-12-28
- 2015-06-30: Accounts Receivable, after Allowance for Credit Loss $11.35M.
- 2014-12-31: Accounts Receivable, after Allowance for Credit Loss $13.85M.
- 2013-12-31: Accounts Receivable, after Allowance for Credit Loss $45.15M.
| Period end | Accounts Receivable, after Allowance for Credit Loss |
|---|---|
| 2015-06-30 | $11.35M 10-Q · filed 2015-12-28 |
| 2014-12-31 | $13.85M 10-K · filed 2015-12-28 |
| 2013-12-31 | $45.15M 10-K · filed 2015-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |